“Now, in fact, there is a queue of manufacturers who want to get into our registration dossier.

Formally, getting into the registration dossier makes it possible to produce this drug, go out with it in civilian circulation, that is, in other words, sell it, "RIA Novosti quotes the director of the center.

Earlier, Gunzburg gave a forecast on the production volumes of the Russian vaccine against the Sputnik V coronavirus. 

On October 20, the director of the Gamaleya Center announced that thousands of doses of the Russian Sputnik V vaccine had already entered civilian circulation.

On October 14, Deputy of the State Duma of the III-V convocations, Doctor of Medical Sciences, Professor, Academician of the Russian Academy of Sciences, Honored Scientist of Russia Sergey Kolesnikov, in an interview with FAN, recalled the features of COVID-19.